Search results
Is Ulcerative Colitis an Autoimmune Disease?
Verywell Health via Yahoo News· 3 months agoMedically reviewed by Jay N. Yepuri, MD Ulcerative colitis is a type of inflammatory bowel disease (IBD). A problem with the immune system leads to...
Is Ulcerative Colitis Curable, or Is Symptom Remission Possible?
Verywell Health via Yahoo News· 6 months agoUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). There is no known cure for...
EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis
Benzinga via Yahoo Finance· 2 years agoThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
How Is Ulcerative Colitis Treated?
Health via Yahoo News· 2 weeks agoMaca and Naca / Getty Images Medically reviewed by Jay N. Yepuri, MD Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that affects the large intestine. Inflammation in the ...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 11 months agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV submitted a new drug application (“NDA”) for ABBV-951 (foscarbidopa/foslevodopa)...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 2 weeks agoThis week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed...